Lyka Labs plans related party transactions up to ₹75 crore with promoter IPCA Laboratories for FY27. This move aims to ensure business continuity but highlights ongoing financial challenges, with a negative Debt Service Coverage Ratio.
Lyka Labs Proposes ₹75 Crore Related Party Deal with Promoter IPCA Labs
Lyka Labs has announced plans for related party transactions (RPTs) with its promoter, IPCA Laboratories Ltd, amounting to ₹75 crore for the financial year 2026-27. The company's Annual General Meeting (AGM) is scheduled for August 10, 2026, to seek shareholder approval for this proposed limit.
Reader Takeaway: Continued promoter reliance for operations versus ongoing financial distress.
What just happened
Lyka Labs is seeking approval for an aggregate transaction limit of ₹75 crore with its promoter, IPCA Laboratories. These transactions include the sale or purchase of goods, contract manufacturing, and Inter-Corporate Deposits. This proposed limit represents a significant portion, 58.39%, of the company's annual consolidated turnover.
Why this matters
For investors, this indicates a substantial ongoing dependence on the promoter for operational activities and working capital. While beneficial for business continuity, it also underscores the company's financial position, as highlighted by its borrowing disclosures. The AGM approval is crucial for these arrangements to proceed.
The backstory
In the previous financial year, FY 2025-26, the value of RPTs stood at ₹29.18 crore. The proposed ₹75 crore for FY 2026-27 signifies an increase in the scale of these transactions between Lyka Labs and IPCA Laboratories.
What changes now
If approved at the AGM, Lyka Labs will have the framework to conduct business up to ₹75 crore with IPCA Laboratories. This will impact the company's debt-to-equity ratio, which is projected to rise to 0.63 post-transaction, and the Debt Service Coverage Ratio (DSCR) is expected to remain negative at -3.18.
Risks to watch
The company faces significant financial risks. The DSCR is a persistent concern, remaining negative at -3.18, indicating an inability to cover debt obligations from operational cash flows. The Debt to Equity ratio is also expected to increase to 0.63. Concentration risk with the promoter is another key area for investors to monitor.
Peer comparison
(No peer comparison data available in the filing)
Context metrics (time-bound)
- Proposed RPT Limit (FY 26-27): ₹75 Crore
- Previous RPT Value (FY 25-26): ₹29.18 Crore
- Promoter Shareholding (IPCA): 40.98%
- Projected Debt to Equity Ratio (Post-RPT): 0.63
- Projected Debt Service Coverage Ratio (Post-RPT): -3.18
What to track next
Investors should closely monitor the outcome of the AGM on August 10, 2026, regarding the RPT approval. Additionally, tracking the company's ability to improve its DSCR and manage its debt levels in subsequent quarters will be critical.